All eyes on Springer’s €2.5bn cov-lite loan
A €2.5bn-equivalent cov-lite loan backing the €3.3bn acquisition of German publisher Springer Science by private equity firm BC Partners should prove no challenge for European investors, according to leveraged loan bankers.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast